Longevity Matters

Longevity
Matters

MORE THAN
LIFE EXTENSION

Longevity science seeks to extend both lifespan—the total number of years a person lives—and healthspan—the years lived in good health, free from chronic disease and disability.

A longer lifespan offers the possibility of more time for personal fulfillment, relationships, and contribution to society, while extending healthspan ensures that those additional years are enjoyed with cognitive clarity, and physical independence. The two goals are deeply interconnected: A longer life is only meaningful when it is accompanied by sustained well-being, making the dual pursuit of lifespan and healthspan central to the mission of longevity science.

We’re not just adding years to life.

We’re adding life to years.

SOLVING A GLOBAL AGING CRISIS

As global populations age, societies are increasingly grappling with the economic and healthcare burdens associated with age-related diseases. These conditions not only reduce quality of life for millions but also place immense strain on healthcare systems, social support networks, and economic productivity.

On a socio-economic level, solving the challenge of healthier aging will extend workforce participation, boost innovation, and strengthen social cohesion.

Longevity science has immense potential, not only to improve individual lives, but to reshape the structure of modern society. It prompts us to rethink how we approach aging, retirement, and intergenerational relationships reimagining the future of public health, economics, and human potential.

The Challenges FACING LONGEVITY SCIENCE

Biological Complexity

Aging involves multiple interconnected biological processes including cellular senescence, mitochondrial dysfunction, telomere attrition, and epigenetic alterations. This complexity requires a systems-level approach to research.

Funding Gaps

Traditional research funding models often overlook early-stage, high-risk longevity research that could lead to breakthrough discoveries. Long development timelines create incentive misalignments.

Regulatory Hurdles

Current regulatory frameworks aren't designed for preventative aging interventions, creating barriers to clinical translation of promising research findings and therapies.

Knowledge Silos

Research findings often remain siloed within institutions, slowing scientific progress. Open collaboration and data sharing are essential for accelerating discoveries in longevity science.

WHAT'S AT STAKE

Reduced healthcare burden through prevention rather than treatment of age-related diseases

Greater intergenerational knowledge transfer and collaboration

Improved cognitive function and mental clarity into advanced age

Expanded workforce productivity and extended contribution periods

Greater opportunity for personal growth and relationship building throughout life

New industries and job markets focused on age-delaying therapeutics, contributing to GDP growth and employment

Extended period of healthy, active life with reduced age-related disease burden for individuals

VitaDAO is reimagining longevity science with a community-powered, decentralized approach to early stage biomedical research. We are uniting a global network of scientists, enthusiasts, and investors to collaboratively fund, support, and govern early-stage longevity research.

Longevity Resources

López-Otín et al. • Cell • 2013

Seminal paper that categorizes the nine hallmarks of aging, providing a framework for understanding aging mechanisms.

Campisi • Journal of Clinical Investigation • 2013

Explores the role of cellular senescence in aging and age-related diseases.

Fontana et al. • Science • 2010

Comprehensive review of interventions that extend lifespan across model organisms.

Worman & Courvalin • Nature Reviews • 2015

Examines nuclear lamin dysfunction in aging and premature aging syndromes.

Hansen et al. • Developmental Cell • 2018

Investigates autophagy's role in longevity using the C. elegans model system.

Verdin • Science • 2015

Reviews NAD+ decline in aging and potential therapeutic interventions to restore levels.

Books & Learning Resources

David Sinclair

Harvard geneticist David Sinclair presents groundbreaking research on aging as a disease that can be slowed, stopped, and even reversed.

Valter Longo

USC researcher Valter Longo shares evidence-based nutritional strategies for promoting longevity and healthspan.

Podcast Series

In-depth interviews with leading longevity researchers, entrepreneurs, and practitioners sharing cutting-edge insights.

Interactive Resource

Comprehensive visual guide to longevity interventions, research areas, and therapeutic approaches.

Research Organizations+ Initiatives

The first independent research facility focused solely on understanding the connection between aging and chronic disease.

Part of NIH, leading the federal effort to support and conduct research on aging and age-related diseases.

Developing rejuvenation biotechnologies to repair the damage of aging and prevent age-related disease.

Advancing scientific research to extend healthy human lifespan through collaborative interdisciplinary approaches.